Concepedia

Jiaxuan Liu

JL

Statistics

Publications

3

Citations

117

H-Index

3

Active since

2020

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

National Cancer Center

Jiaxuan Liu is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in cancer pharmacology, metastatic breast cancer, and cancer immunotherapy.

ORCID

Publications per year

2020–2024

3

Publications

3

The anti-PD-L1/CTLA-4 bispecific antibody KN046 in combination with nab-paclitaxel in first-line treatment of metastatic triple-negative breast cancer: a multicenter phase II trial

Qiao Li, Jiaxuan Liu, Qingyuan Zhang et al. · Nature Communications · 2024 · 76 citations · Full text

, , +17

Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial

Zijing Wang, Jiaxuan Liu, Fei Ma et al. · Breast Cancer Research and Treatment · 2021 · 22 citations · Full text

, , +17

MiR-34c promotes hepatic stellate cell activation and Liver Fibrogenesis by suppressing ACSL1 expression

Binbin Li, Jiaxuan Liu, Xuan Xin et al. · International Journal of Medical Sciences · 2020 · 19 citations · Full text

, , +17

1–3 of 3